NICE approval for nivolumab provides new treatment for advanced blood cancer
People with an advanced type of blood cancer will benefit from nivolumab on the NHS following approval by NICE.
Latest news headlines
People with advanced kidney cancer are set to benefit from a new treatment, after NICE has said cabozantinib should be available on the NHS.
10 July 2017
An agreement has been reached that means more people with a rare life threatening disease can be offered an innovative new drug.
05 July 2017
Paramedics with advanced training can reduce the number of patients admitted to hospital unnecessarily, says NICE.
03 July 2017
Bylaws could be introduced as a way to enforce ‘no vehicle idling’ in areas where vulnerable people collect (for example schools, hospitals and care homes).
30 June 2017
NHS patients in England are getting early access to new drugs for lung cancer and sarcoma, after NICE says they should be available on the Cancer Drugs Fund (CDF).
28 June 2017
NICE Scientific Advice has launched a competition for small or medium sized companies, charities and academic research groups, who are developing transformative products that have the potential to change patients’ lives and/or save the NHS money.
27 June 2017